Assessment of Response Rates and Yields for Two Tools for Early Detection of Non-diabetic Hyperglycaemia and Diabetes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00950313

Acronym

ATTEND

Enrollment

432

Registered

2009-07-31

Start date

2011-04-30

Completion date

2014-07-31

Last updated

2020-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Diabetes, Screening, Risk, Self assessment

Brief summary

The purpose of this study is to establish the most effective method of increasing attendance to screening of type 2 Diabetes within a primary care setting within the backdrop of the NHS Health Check programme.

Detailed description

The University Hospitals of Leicester and The University of Leicester have developed a self-assessment risk score and a practice data risk score that can be used in a variety of setting to detect undiagnosed diabetes and impaired glucose regulation. This is done to establish a simple and effective 1st stage screen to identify those people at risk of diabetes and engage the public to increase the number of high risk individuals attending screening invitations but reducing the overall number of oral glucose tolerance tests. This study aims to test in a pragmatic way the use of such tools in a primary care setting administered by primary care staff as part of the NHS Health Check programme.

Interventions

OTHERSelf Assessment

Self assessment used to determine current risk of diabetes and likelihood of requiring further testing

OTHERElectronic risk score

Patients current risk of diabetes is determined by a electronic risk algorithm. They are then invited to attend fof further testing.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* 40-75 years old (30 -75 years old if South Asian origin)

Exclusion criteria

* Current diagnosis of diabetes * Terminal illness or mental incapacity

Design outcomes

Primary

Measure	Time frame
Increase in response rates to invitation to 2nd stage blood test	12 months

Secondary

Measure	Time frame
Increase in yield of OGTT positive results through filtering of high risk participants that pass 1st and 2nd stage screens	12

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026